SUPPLEMENT
Q4 2020 — Sales of Key Products/Franchises
Q4 2020PDF · 4 pages211 KB
REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) FOURTH QUARTER TWELVE MONTHS 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency CONSUMER HEALTH SEGMENT (2,3) OTC US 543 $ 542 0.1% 0.1% - 2,460 $ 2,010 22.4% 22.4% - Intl 642 653 -1.7% -2.9% 1.2% 2,364 2,434 -2.9% -1.2% -1.7% WW 1,185 1,195 -0.8% -1.5% 0.7% 4,824 4,444 8.5% 9.4% -0.9% SKIN HEALTH / BEAUTY (4) US 583 582 0.2% 0.2% - 2,350 2,392 -1.7% -1.7% - Intl 594 568 4.6% 5.0% -0.4% 2,100 2,201 -4.6% -2.3% -2.3% WW 1,177 1,150 2.4% 2.6% -0.2% 4,450 4,593 -3.1% -2.0% -1.1% ORAL CARE US 173 159 8.3% 8.3% - 683 621 9.9% 9.9% - Intl 264 233 13.5% 14.5% -1.0% 958 906 5.7% 9.6% -3.9% WW 437 393 11.4% 12.0% -0.6% 1,641 1,528 7.4% 9.7% -2.3% BABY CARE US 97 85 14.3% 14.3% - 376 362 3.7% 3.7% - Intl 310 336 -7.8% -3.6% -4.2% 1,141 1,313 -13.1% -7.3% -5.8% WW 407 421 -3.4% 0.0% -3.4% 1,517 1,675 -9.4% -4.9% -4.5% WOMEN'S HEALTH US 3 3 11.8% 11.8% - 13 12 8.2% 8.2% - Intl 234 250 -6.5% -3.1% -3.4% 888 974 -8.8% -2.9% -5.9% WW 237 253 -6.3% -2.9% -3.4% 901 986 -8.6% -2.7% -5.9% WOUND CARE / OTHER US 110 98 11.8% 11.8% - 480 441 8.9% 8.9% - Intl 65 57 12.4% 13.0% -0.6% 240 230 4.1% 7.3% -3.2% WW 175 155 12.0% 12.2% -0.2% 720 671 7.2% 8.3% -1.1% TOTAL CONSUMER HEALTH US 1,509 1,470 2.7% 2.7% - 6,362 5,839 9.0% 9.0% - Intl 2,109 2,097 0.5% 1.5% -1.0% 7,691 8,059 -4.6% -1.3% -3.3% WW 3,618 $ 3,567 1.4% 2.0% -0.6% 14,053 $ 13,898 1.1% 3.0% -1.9% See footnotes at end of schedule % Change % Change -- 1 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) FOURTH QUARTER TWELVE MONTHS PHARMACEUTICAL SEGMENT (2,5) 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency IMMUNOLOGY US 2,845 $ 2,517 13.0% 13.0% - 10,175 $ 9,641 5.5% 5.5% - Intl 1,261 1,005 25.4% 21.1% 4.3% 4,880 4,309 13.2% 14.0% -0.8% WW 4,105 3,522 16.6% 15.3% 1.3% 15,055 13,950 7.9% 8.2% -0.3% REMICADE US 656 755 -13.1% -13.1% - 2,508 3,079 -18.5% -18.5% - US Exports (6) 25 68 -62.4% -62.4% - 346 294 18.0% 18.0% - Intl 220 212 3.3% 2.7% 0.6% 893 1,007 -11.4% -8.6% -2.8% WW 901 1,035 -12.9% -13.1% 0.2% 3,747 4,380 -14.4% -13.8% -0.6% SIMPONI / SIMPONI ARIA US 315 302 4.4% 4.4% - 1,155 1,159 -0.3% -0.3% - Intl 261 213 22.9% 18.8% 4.1% 1,088 1,029 5.8% 7.0% -1.2% WW 576 515 12.1% 10.4% 1.7% 2,243 2,188 2.6% 3.1% -0.5% STELARA US 1,572 1,194 31.6% 31.6% - 5,240 4,346 20.6% 20.6% - Intl 672 506 32.7% 27.2% 5.5% 2,467 2,015 22.4% 22.2% 0.2% WW 2,244 1,700 31.9% 30.3% 1.6% 7,707 6,361 21.1% 21.1% 0.0% TREMFYA US 276 199 39.1% 39.1% - 926 764 21.3% 21.3% - Intl 105 71 48.1% 40.0% 8.1% 421 248 69.9% 67.9% 2.0% WW 382 270 41.5% 39.3% 2.2% 1,347 1,012 33.2% 32.7% 0.5% OTHER IMMUNOLOGY US - - - - - - - - - - Intl 2 2 -19.7% -14.5% -5.2% 11 10 6.4% 12.8% -6.4% WW 2 2 -19.7% -14.5% -5.2% 11 10 6.4% 12.8% -6.4% INFECTIOUS DISEASES US 470 435 7.9% 7.9% - 1,735 1,597 8.6% 8.6% - Intl 442 430 2.8% -2.6% 5.4% 1,839 1,815 1.3% 2.2% -0.9% WW 912 866 5.4% 2.7% 2.7% 3,574 3,413 4.7% 5.2% -0.5% EDURANT / rilpivirine US 11 14 -17.9% -17.9% - 44 50 -11.2% -11.2% - Intl 236 209 13.4% 6.2% 7.2% 920 812 13.3% 11.9% 1.4% WW 248 222 11.4% 4.7% 6.7% 964 861 11.9% 10.5% 1.4% PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA US 433 390 11.1% 11.1% - 1,587 1,422 11.6% 11.6% - Intl 136 155 -12.4% -17.1% 4.7% 597 689 -13.4% -10.7% -2.7% WW 569 544 4.4% 3.1% 1.3% 2,184 2,110 3.5% 4.4% -0.9% OTHER INFECTIOUS DISEASES US 25 32 -20.4% -20.4% - 104 126 -17.6% -17.6% - Intl 71 67 5.2% 3.3% 1.9% 323 315 2.6% 5.6% -3.0% WW 96 99 -3.0% -4.3% 1.3% 427 441 -3.2% -1.0% -2.2% % Change % Change -- 2 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) FOURTH QUARTER TWELVE MONTHS 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency NEUROSCIENCE US 806 747 7.9% 7.9% - 3,091 2,919 5.9% 5.9% - Intl 892 819 9.0% 6.2% 2.8% 3,457 3,409 1.4% 2.2% -0.8% WW 1,698 1,566 8.5% 7.0% 1.5% 6,548 6,328 3.5% 3.9% -0.4% CONCERTA / Methylphenidate US 33 37 -9.7% -9.7% - 183 233 -21.4% -21.4% - Intl 120 115 4.2% 1.4% 2.8% 439 463 -5.1% -4.5% -0.6% WW 153 152 0.9% -1.2% 2.1% 622 696 -10.6% -10.2% -0.4% INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA US 610 564 8.1% 8.1% - 2,314 2,107 9.8% 9.8% - Intl 355 308 15.7% 10.8% 4.9% 1,339 1,224 9.4% 9.1% 0.3% WW 965 871 10.8% 9.0% 1.8% 3,653 3,330 9.7% 9.6% 0.1% RISPERDAL CONSTA US 76 77 -2.5% -2.5% - 296 314 -5.9% -5.9% - Intl 92 82 11.0% 7.7% 3.3% 346 374 -7.5% -6.9% -0.6% WW 167 160 4.4% 2.7% 1.7% 642 688 -6.8% -6.4% -0.4% OTHER NEUROSCIENCE US 88 70 27.4% 27.4% - 298 266 12.4% 12.4% - Intl 326 314 3.7% 3.1% 0.6% 1,334 1,349 -1.1% 0.7% -1.8% WW 414 383 8.0% 7.5% 0.5% 1,632 1,614 1.1% 2.6% -1.5% ONCOLOGY US 1,469 1,153 27.4% 27.4% - 5,092 4,299 18.5% 18.5% - Intl 1,965 1,563 25.7% 20.9% 4.8% 7,275 6,393 13.8% 14.0% -0.2% WW 3,434 2,716 26.4% 23.7% 2.7% 12,367 10,692 15.7% 15.8% -0.1% DARZALEX US 692 444 55.6% 55.6% - 2,232 1,567 42.4% 42.4% - Intl 561 385 45.4% 41.3% 4.1% 1,958 1,430 36.9% 38.0% -1.1% WW 1,253 830 50.9% 49.0% 1.9% 4,190 2,998 39.8% 40.3% -0.5% ERLEADA US 176 103 70.8% 70.8% - 583 297 96.1% 96.1% - Intl 64 13 * * * 176 35 * * * WW 241 116 * * * 760 332 * * * IMBRUVICA US 492 392 25.8% 25.8% - 1,821 1,555 17.1% 17.1% - Intl 625 483 29.3% 24.8% 4.5% 2,307 1,856 24.3% 25.1% -0.8% WW 1,117 875 27.8% 25.3% 2.5% 4,128 3,411 21.0% 21.5% -0.5% VELCADE US - - - - - - - - - - Intl 97 115 -15.2% -18.5% 3.3% 408 751 -45.7% -45.8% 0.1% WW 97 115 -15.2% -18.5% 3.3% 408 751 -45.7% -45.8% 0.1% ZYTIGA / abiraterone acetate US 89 194 -54.3% -54.3% - 373 810 -54.0% -54.0% - Intl 533 483 10.2% 4.3% 5.9% 2,097 1,985 5.6% 4.7% 0.9% WW 622 677 -8.3% -12.5% 4.2% 2,470 2,795 -11.6% -12.3% 0.7% OTHER ONCOLOGY US 20 19 2.6% 2.6% - 83 70 19.2% 19.2% - Intl 86 84 1.5% -2.1% 3.6% 330 336 -1.9% -1.4% -0.5% WW 105 104 1.7% -1.2% 2.9% 413 407 1.7% 2.2% -0.5% PULMONARY HYPERTENSION US 592 388 52.5% 52.5% - 2,133 1,684 26.6% 26.6% - Intl 273 235 16.8% 12.5% 4.3% 1,015 939 8.2% 8.0% 0.2% WW 865 623 39.0% 37.4% 1.6% 3,148 2,623 20.0% 20.0% 0.0% OPSUMIT US 279 185 52.1% 52.1% - 1,008 766 31.7% 31.7% - Intl 173 143 21.2% 16.9% 4.3% 631 562 12.3% 12.3% 0.0% WW 452 326 38.6% 36.7% 1.9% 1,639 1,327 23.5% 23.5% 0.0% UPTRAVI US 263 178 48.2% 48.2% - 955 714 33.8% 33.8% - Intl 38 30 25.5% 20.1% 5.4% 138 105 30.9% 30.5% 0.4% WW 301 208 44.9% 44.1% 0.8% 1,093 819 33.5% 33.4% 0.1% OTHER PULMONARY HYPERTENSION US 49 26 84.9% 84.9% - 169 205 -17.6% -17.6% - Intl 63 62 2.4% -1.2% 3.6% 247 272 -9.2% -9.4% 0.2% WW 112 88 26.6% 24.1% 2.5% 416 476 -12.8% -12.9% 0.1% CARDIOVASCULAR / METABOLISM / OTHER US 935 930 0.6% 0.6% - 3,509 3,734 -6.0% -6.0% - Intl 317 327 -2.6% -5.4% 2.8% 1,369 1,458 -6.1% -4.8% -1.3% WW 1,253 1,256 -0.2% -1.0% 0.8% 4,878 5,192 -6.0% -5.7% -0.3% XARELTO US 629 609 3.1% 3.1% - 2,345 2,313 1.4% 1.4% - Intl - - - - - - - - - - WW 629 609 3.1% 3.1% - 2,345 2,313 1.4% 1.4% - INVOKANA / INVOKAMET US 159 125 27.7% 27.7% - 564 536 5.2% 5.2% - Intl 58 52 11.5% 8.9% 2.6% 231 199 16.3% 17.6% -1.3% WW 217 177 22.9% 22.1% 0.8% 795 735 8.2% 8.6% -0.4% PROCRIT / EPREX US 62 118 -46.9% -46.9% - 277 505 -45.1% -45.1% - Intl 66 65 2.0% -1.1% 3.1% 274 285 -3.8% -3.6% -0.2% WW 129 183 -29.5% -30.6% 1.1% 552 790 -30.2% -30.1% -0.1% OTHER US 85 78 9.4% 9.4% - 323 380 -15.1% -15.1% - Intl 194 209 -7.6% -10.3% 2.7% 864 974 -11.3% -9.7% -1.6% WW 278 286 -3.0% -5.0% 2.0% 1,186 1,353 -12.4% -11.2% -1.2% TOTAL PHARMACEUTICAL US 7,116 6,169 15.3% 15.3% - 25,735 23,874 7.8% 7.8% - Intl 5,152 4,379 17.7% 13.5% 4.2% 19,837 18,324 8.3% 8.8% -0.5% WW 12,268 $ 10,548 16.3% 14.6% 1.7% 45,572 $ 42,198 8.0% 8.2% -0.2% See footnotes at end of schedule % Change % Change -- 3 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) FOURTH QUARTER TWELVE MONTHS MEDICAL DEVICES SEGMENT (2,5) 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency INTERVENTIONAL SOLUTIONS US 433 $ 377 14.8% 14.8% - 1,452 1,443 0.6% 0.6% - Intl 460 398 15.7% 10.8% 4.9% 1,594 1,554 2.6% 2.0% 0.6% WW 893 774 15.3% 12.8% 2.5% 3,046 2,997 1.6% 1.3% 0.3% ORTHOPAEDICS US 1,352 1,369 -1.3% -1.3% - 4,779 5,319 -10.2% -10.2% - Intl 839 904 -7.3% -11.3% 4.0% 2,984 3,520 -15.2% -15.4% 0.2% WW 2,191 2,273 -3.7% -5.3% 1.6% 7,763 8,839 -12.2% -12.3% 0.1% HIPS US 229 230 -0.7% -0.7% - 793 863 -8.2% -8.2% - Intl 143 147 -2.2% -5.8% 3.6% 487 575 -15.3% -15.1% -0.2% WW 372 377 -1.3% -2.7% 1.4% 1,280 1,438 -11.0% -11.0% 0.0% KNEES US 216 239 -9.5% -9.5% - 743 889 -16.4% -16.4% - Intl 129 156 -17.2% -20.6% 3.4% 427 591 -27.8% -28.0% 0.2% WW 345 395 -12.5% -13.9% 1.4% 1,170 1,480 -21.0% -21.1% 0.1% TRAUMA US 454 413 10.0% 10.0% - 1,648 1,652 -0.2% -0.2% - Intl 268 273 -2.0% -6.2% 4.2% 966 1,068 -9.6% -9.7% 0.1% WW 722 686 5.2% 3.6% 1.6% 2,614 2,720 -3.9% -3.9% 0.0% SPINE, SPORTS & OTHER (7) US 453 488 -7.1% -7.1% - 1,595 1,915 -16.7% -16.7% - Intl 299 329 -9.2% -13.6% 4.4% 1,104 1,286 -14.1% -14.6% 0.5% WW 752 817 -7.9% -9.7% 1.8% 2,699 3,201 -15.7% -15.9% 0.2% SURGERY US 1,002 961 4.3% 4.3% - 3,249 3,828 -15.1% -15.1% - Intl 1,427 1,481 -3.7% -5.9% 2.2% 4,983 5,673 -12.2% -11.2% -1.0% WW 2,429 2,442 -0.5% -1.9% 1.4% 8,232 9,501 -13.4% -12.8% -0.6% ADVANCED US 456 428 6.5% 6.5% - 1,535 1,637 -6.2% -6.2% - Intl 660 647 2.1% -0.9% 3.0% 2,304 2,458 -6.2% -5.6% -0.6% WW 1,116 1,076 3.8% 2.0% 1.8% 3,839 4,095 -6.2% -5.8% -0.4% GENERAL US 546 534 2.5% 2.5% - 1,714 2,192 -21.8% -21.8% - Intl 767 834 -8.1% -9.8% 1.7% 2,679 3,215 -16.7% -15.5% -1.2% WW 1,312 1,366 -4.0% -5.0% 1.0% 4,392 5,406 -18.8% -18.0% -0.8% VISION US 397 428 -7.3% -7.3% - 1,557 1,794 -13.2% -13.2% - Intl 679 713 -4.7% -6.2% 1.5% 2,362 2,830 -16.5% -16.2% -0.3% WW 1,076 1,141 -5.7% -6.6% 0.9% 3,919 4,624 -15.2% -15.1% -0.1% CONTACT LENSES / OTHER US 289 311 -7.4% -7.4% - 1,213 1,304 -7.0% -7.0% - Intl 507 522 -2.7% -4.1% 1.4% 1,781 2,088 -14.7% -14.4% -0.3% WW 796 833 -4.4% -5.3% 0.9% 2,994 3,392 -11.7% -11.5% -0.2% SURGICAL US 108 117 -7.1% -7.1% - 344 490 -29.7% -29.7% - Intl 172 191 -10.3% -12.0% 1.7% 581 742 -21.7% -21.5% -0.2% WW 280 309 -9.1% -10.1% 1.0% 925 1,232 -24.9% -24.7% -0.2% TOTAL MEDICAL DEVICES US 3,184 3,135 1.5% 1.5% - 11,036 12,384 -10.9% -10.9% - Intl 3,405 3,497 -2.6% -5.5% 2.9% 11,923 13,579 -12.2% -11.8% -0.4% WW 6,589 $ 6,632 -0.7% -2.2% 1.5% 22,959 $ 25,963 -11.6% -11.4% -0.2% * Percentage greater than 100% or not meaningful (6) Reported as U.S. sales (1) Operational growth excludes the effect of translational currency (7) Previously referred to as Spine & Other (2) Unaudited (3) Previously referred to as Consumer (4) Previously referred to as Beauty (5) Certain prior year amounts have been reclassified to conform to current year product disclosures Note: Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. % Change % Change -- 4 of 4 --